![Page 1: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/1.jpg)
Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest
Richard Levenson, MD
Dept. of Pathology and
Laboratory Medicine
UC Davis Medical Center
![Page 2: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/2.jpg)
Themes
1.The stroma (not the epithelium) may be key (…“STROMICS”)
2.“Systems biology” is most relevant at structural, intercellular and tissue levels
3.Bonus: glimpse of novel structural (target: collagen) and multiplexed (target: heterogeneity) imaging technologies
![Page 3: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/3.jpg)
Are we looking in the right places?
How might a focus on micro-environment and host factors affect diagnosis and treatment strategies?
![Page 4: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/4.jpg)
Normal breast
![Page 5: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/5.jpg)
![Page 6: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/6.jpg)
Invasive squamous cell carcinoma
![Page 7: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/7.jpg)
Gabriella dental x-ray and CT: loss of bone
Nov, 2011 Feb, 2012
![Page 8: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/8.jpg)
![Page 9: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/9.jpg)
![Page 10: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/10.jpg)
14 months later…
![Page 11: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/11.jpg)
Implications:
New therapies will need new companion diagnostics—or perhaps none…
Molecular phenotypes in spatial context can be informative
Coming up:
Multiplexed imaging
Selection of targets
![Page 12: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/12.jpg)
12
How well could we understand the battle of Waterloo…if we blenderized the battlefield?
![Page 13: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/13.jpg)
Spectral imaging variants
PARISS
NUANCE/VECTRALCTF
HSi-440cAOTF
RebellionIMS
![Page 14: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/14.jpg)
Vectra: Evaluating EMT in FFPE-Tissue Sections
C. Hoyt, PerkinElmer, Inc.; C. Gagen & R. Wetzel, Cell Signaling Technology
DAPI E-cadherin vimentin
![Page 15: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/15.jpg)
Raw color image
Immunofluorescence with quantum dots
DAPIPR (585-nm QDot)ER (655-nm QDot)Convert to brightfieldDAPI and autofluorescence
![Page 16: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/16.jpg)
16
From Mouse to Microscope: Breast cancer and Cy5-anti-Her2 antibody
Courtesy Roche, Penzberg, Germany
![Page 17: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/17.jpg)
17
Four nuclear signals can be distinguished using chromogens in brightfield
Hematoxylin
Ki67—red cell cycle
pHH3—brown cell cycle
CC3—gray antiangiogenesis met. suppressor
![Page 18: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/18.jpg)
Great tools and reagents…
So what compartments and components should we be looking at?
(hint: stroma)
![Page 19: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/19.jpg)
Nature Medicine, 2008
Top 200 gene expression levels most different between microdissected normal and tumor-associated stroma.
Automatic clustering gave these recurrence-free survival curves
![Page 20: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/20.jpg)
26-gene stromal signature is independent of all major clinical and pathological variables:
• ER • HER2• lymph node status • age• grade• tumor size
NOT PREDICTIVE!
![Page 21: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/21.jpg)
C-Path: ‘Omic’s approach to the analysis of tumor morphology
AH Beck, …, D Koller. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Science Translational Medicine 2011. 3, 108ra113.
![Page 22: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/22.jpg)
Seventy-gene prognosis signature Size Invasiveness gene signature Mastectomy Wound response signature ERBB2 molecular subtype Grade Basal molecular subtype ER Lymph node Genomic grade index Luminal A molecular subtype Luminal B molecular subtype Chemotherapy
NOTSIGNIFICANT:
Classic tumor characteristics are not predictive
Andy Beck
![Page 23: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/23.jpg)
• C-Path score • Hypoxia • Age
What is significant:
Just 3 stromal features predicted outcome better than 8 epithelial features
Moreover:
Andy Beck
![Page 24: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/24.jpg)
Untreated Treated
2009
![Page 25: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/25.jpg)
Tumor heterogeneity: Stromal environment affects stemness and HER2-positivity
(Stem cell marker)
In this case, HER2- induction NOT due to gene amplification
Implications for HER2 IHC and ISH assays?
Wicha 2013
![Page 26: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/26.jpg)
What about structural properties of the stroma?
Can we detect them in tissue slices?
![Page 27: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/27.jpg)
Boyd et al. Breast Cancer Research 2011 13:223
OR 1 1.7 2.1 2.4 4.7
Mammographic density affects the risk of breast cancer
0 <10 <25
<50 <75 >75
![Page 28: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/28.jpg)
28
Stromal rearrangement around cancer can reflect biological properties
Linear collagen strands oriented tangentially (0 degrees)
Linear collagen strands oriented at 90 degrees
Non-invasive tumor
Locally invasive tumor
(Second harmonic generation imaging)
Provenzano et al., BMC 2008
![Page 29: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/29.jpg)
TACS-2 TACS-3
Locker and Segal commentary on Conklin et al, AJP, 2011
Risk independent of:GradeSizeAgeER/PR/HER-2node status
Conklin et al, AJP, 2011
DISEASE-FREE SURVIVAL
![Page 30: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/30.jpg)
SHG: complex, expensive
![Page 31: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/31.jpg)
Inexpensive collagen detection
![Page 32: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/32.jpg)
Tissue microarray sample: low magnification
![Page 33: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/33.jpg)
Orientation of fibers viewed with color map
Bile duct in cirrhotic liver
![Page 34: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/34.jpg)
Sneak preview: Subcellular-resolution multiplexed MS
Conventional imaging mass spec: spatial resolution ~35 microns
(Images by Richard Caprioli, keynote speaker at a previous Tucson Symposium)
![Page 35: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/35.jpg)
Sneak preview: Subcellular-resolution multiplexed MS
![Page 36: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/36.jpg)
Hematoxylin and Ki-67 imaged via mass spec
Spatial resolution < 1 micron
![Page 37: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/37.jpg)
![Page 38: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/38.jpg)
Large field of view, high-resolution mass-spec image
![Page 39: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/39.jpg)
So what’s coming?
•Stromics •“Companion diagnostics” regime not
going away …(so ER/PR/Her2 etc. will be around for a while)
•… but disruptive therapies will alter the diagnostic landscape
•Spatially resolved, highly multiplexed subcellular-scale molecular and structural profiling is feasible
•New tools--and new paradigms—should allow us to see the leaves, the trees and the forest.
![Page 40: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/40.jpg)
Prognosis: encouraging
![Page 41: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/41.jpg)
The Venezuelan Poodle Moth is a possible new species of moth discovered in 2009 by Dr. Arthur Anker of Bishkek, Kyrgyzstan.
![Page 42: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/42.jpg)
Snapshot collagen birefringence image of an H&E-stained breast cancer sample
![Page 43: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/43.jpg)
Notes
• Instead of using canonical cell surface markers to identify leukemia stem cells (LSCs), Lagadinou et al. apply a functional approach… of ROS measurements: …both novel and potentially of great utility.
• Cell Stem Cell. 2013 Jan 15.
• BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells.
• The Bcl-2 gene has been implicated in a number of cancers, including melanoma, breast, prostate, chronic lymphocytic leukemia, and lung carcinomas.
• “We demonstrate here that it is feasible to eradicate resistant LSC populations by targeting their unique metabolic dependencies.”
![Page 44: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/44.jpg)
Simple antigen-positivity measurements in bulk tumors may be simplistic
Yellow = HER2(+) stem cells (not bulk population)
Wicha, 2013
![Page 45: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/45.jpg)
FT-SHG: tissue-scale featureschange optics, then:
P-SHG: molecular organization(6 measurements required)
N.B.: Half the malignant stroma is “normal,” and localized features important, so imaging is necessary
![Page 46: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/46.jpg)
-1
0
1
2
3
4
5
6
7
0 10 20 30 40 50 60 70 80 90 100
Tumor Transplantation (days)
Tu
mo
r B
urd
en (
cm3 )
Left Inguinal (Control rat)Right Axillary (Control rat)Left Axillary (Control rat)Right Axillary (Cured rat)Left Axillary (Cured rat)
Death
Effect of immunophotonic therapy on primary and metastatic tumors in rats
Primary
Mets
CD8 cell attacking a tumor cell
![Page 47: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/47.jpg)
Tumor Immunotherapy: Stage 4 breast cancer
![Page 48: Multiplexed Imaging, Pathology and Personalized Medicine: Keeping Sight of the Forest](https://reader037.vdocuments.mx/reader037/viewer/2022102804/544ff017af795993468b51c6/html5/thumbnails/48.jpg)
Biology of tumor progression meets biology of aging